Hepatocyte growth factor is predominantly expressed by the carcinoma cells in non-small-cell lung cancer.

Hepatocyte growth factor (HGF) exerts multifunctional regulatory roles in the growth, morphogenesis, differentiation, and motility of epithelial cells, and putatively plays important roles in tumor angiogenesis and metastasis. Aside from the full-length protein, 2 naturally occurring truncated HGF isoforms (NK1 and NK2) have been identified. Recent evidence suggests that a high level of HGF in surgically resected non-small-cell lung carcinoma (NSCLC) is a negative prognostic marker for NSCLC patients' survival. The origin of HGF in these tumors remains uncertain. We show here by in situ hybridization and immunohistochemistry that HGF messenger RNA (mRNA) and protein were predominantly expressed by the tumor cells in a high percentage of primary NSCLC. Stromal cell expression of HGF was limited to some lymphocytes and endothelial cells. Normal bronchial and bronchiolar epithelial cells also expressed HGF mRNA and immunoreactive protein. The mRNA transcripts and putative proteins of all 3 known HGF isoforms were detected in both normal lung and lung cancer tissues, but the full-length HGF was predominantly expressed. Our findings indicate that both autocrine and paracrine functions of HGF are likely to contribute to the pathobiology of lung cancer in vivo.

[1]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[2]  M. Tsao,et al.  Activation of hepatocyte growth factor-met autocrine loop enhances tumorigenicity in a human lung adenocarcinoma cell line. , 2000, Neoplasia.

[3]  R. Sharp,et al.  c-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype. , 1998, Cancer research.

[4]  M. Tsao,et al.  The roles of hepatocyte growth factor/scatter factor and met receptor in human cancers (Review). , 1998, Oncology reports.

[5]  T. Nakamura,et al.  Paracrine effects of hepatocyte growth factor/scatter factor on non-small-cell lung carcinoma cell lines. , 1998, British Journal of Cancer.

[6]  M. Tsao,et al.  Differential expression of Met/hepatocyte growth factor receptor in subtypes of non-small cell lung cancers. , 1998, Lung cancer.

[7]  G. Merlino,et al.  NK1, a Natural Splice Variant of Hepatocyte Growth Factor/Scatter Factor, Is a Partial Agonist In Vivo , 1998, Molecular and Cellular Biology.

[8]  W. Birchmeier,et al.  Role of morphogenetic factors in metastasis of mammary carcinoma cells , 1998, Oncogene.

[9]  E. Rosen,et al.  Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[10]  L. Jin,et al.  Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[11]  L. Weissfeld,et al.  Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer. , 1997, Cancer research.

[12]  R. Sharp,et al.  Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[13]  R. Ball,et al.  IMMUNOREACTIVITY FOR HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR AND ITS RECEPTOR, met, IN HUMAN LUNG CARCINOMAS AND MALIGNANT MESOTHELIOMAS , 1996, The Journal of pathology.

[14]  P. Comoglio,et al.  Overexpression and activation of hepatocyte growth factor/scatter factor in human non-small-cell lung carcinomas. , 1996, British Journal of Cancer.

[15]  J. Rubin,et al.  Hepatocyte growth factor/scatter factor overexpression induces growth, abnormal development, and tumor formation in transgenic mouse livers. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[16]  T. Nakajima,et al.  Expression of c‐met/HGF Receptor in Human Non‐small Cell Lung Carcinomas in vitro and in vivo and Its Prognostic Significance , 1996, Japanese journal of cancer research : Gann.

[17]  T. Yamamoto,et al.  Hepatocyte growth factor and c-Met/hepatocyte growth factor receptor in pulmonary adenocarcinomas: an evaluation of their expression as prognostic markers. , 1996, Oncology.

[18]  J. Rubin,et al.  Hepatocyte Growth Factor (HGF)/NK1 Is a Naturally Occurring HGF/Scatter Factor Variant with Partial Agonist/Antagonist Activity* , 1996, The Journal of Biological Chemistry.

[19]  K. Bauer,et al.  Heparin induces dimerization and confers proliferative activity onto the hepatocyte growth factor antagonists NK1 and NK2 , 1996, The Journal of cell biology.

[20]  T. Nakamura,et al.  Hepatocyte growth factor in lung morphogenesis and tumor invasion: role as a mediator in epithelium-mesenchyme and tumor-stroma interactions , 1996, Cancer Chemotherapy and Pharmacology.

[21]  M. Tsao,et al.  Hepatocyte growth factor and Met receptor expression in human pancreatic carcinogenesis. , 1995, The American journal of pathology.

[22]  J. Siegfried,et al.  Stimulatory effects of hepatocyte growth factor on normal and neoplastic human bronchial epithelial cells. , 1995, The American journal of physiology.

[23]  L. Orci,et al.  Hepatocyte growth factor stimulates extensive development of branching duct-like structures by cloned mammary gland epithelial cells. , 1995, Journal of cell science.

[24]  E. Rosen,et al.  Scatter factor and the c-met receptor: a paradigm for mesenchymal/epithelial interaction , 1994, The Journal of cell biology.

[25]  C. Leslie,et al.  Hepatocyte growth factor is a growth factor for rat alveolar type II cells. , 1994, American journal of respiratory cell and molecular biology.

[26]  K. Matsumoto,et al.  Autocrine stimulation of motility in SBC-5 human lung carcinoma cells by a two-kringle variant of HGF. , 1994, Cancer letters.

[27]  Yufei Wang,et al.  Hepatocyte growth factor/scatter factor expression in human mammary epithelium. , 1994, The American journal of pathology.

[28]  S. Hirohashi,et al.  Immunohistochemical Detection of Hepatocyte Growth Factor/Scatter Factor in Human Cancerous and Inflammatory Lesions of Various Organs , 1993, Japanese journal of cancer research : Gann.

[29]  P. Godowski,et al.  Generation and characterization of a competitive antagonist of human hepatocyte growth factor, HGF/NK1. , 1993, The Journal of biological chemistry.

[30]  T. Nakamura,et al.  Hepatocyte growth factor/scatter factor is an autocrine factor for human normal bronchial epithelial and lung carcinoma cells. , 1993, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[31]  K. Matsumoto,et al.  Hepatocyte growth factor induces proliferation and morphogenesis in nonparenchymal epithelial liver cells , 1993, Hepatology.

[32]  M. Tsao,et al.  In vitro and in vivo expressions of transforming growth factor-alpha and tyrosine kinase receptors in human non-small-cell lung carcinomas. , 1993, The American journal of pathology.

[33]  T. Nakamura,et al.  Hepatocyte growth factor inhibits growth of hepatocellular carcinoma cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[34]  M. Tsao,et al.  Overexpression of c-met proto-oncogene but not epidermal growth factor receptor or c-erbB-2 in primary human colorectal carcinomas. , 1992, Oncogene.

[35]  J. Rubin,et al.  Identification of a competitive HGF antagonist encoded by an alternative transcript. , 1991, Science.

[36]  E Medico,et al.  Expression of the Met/HGF receptor in normal and neoplastic human tissues. , 1991, Oncogene.

[37]  Toshikazu Nakamura,et al.  Hepatocyte growth factor has potent anti‐proliferative activity in various tumor cell lines , 1991, FEBS letters.

[38]  K. Matsumoto,et al.  Marked stimulation of growth and motility of human keratinocytes by hepatocyte growth factor. , 1991, Experimental cell research.

[39]  L. Orci,et al.  Induction of epithelial tubular morphogenesis in vitro by fibroblast-derived soluble factors , 1991, Cell.

[40]  W. Birchmeier,et al.  Evidence for the identity of human scatter factor and human hepatocyte growth factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[41]  K. Miyazawa,et al.  An alternatively processed mRNA generated from human hepatocyte growth factor gene. , 1991, European journal of biochemistry.

[42]  G. Michalopoulos,et al.  Hepatocyte growth factor/hepatopoietin A stimulates the growth of rat kidney proximal tubule epithelial cells (RPTE), rat nonparenchymal liver cells, human melanoma cells, mouse keratinocytes and stimulates anchorage-independent growth of SV-40 transformed RPTE. , 1991, Biochemical and biophysical research communications.

[43]  W. Birchmeier,et al.  Evidence for the identy of human scatter factor and human hepatocyte growth factor. , 1991 .

[44]  K. Tashiro,et al.  Molecular cloning and expression of human hepatocyte growth factor , 1989, Nature.

[45]  E. Gherardi,et al.  Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interactions and movement. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[46]  Michael Stoker,et al.  Scatter factor is a fibroblast-derived modulator of epithelial cell mobility , 1987, Nature.